Comparative Effectiveness and Outcomes Research
This division pursues comparative effectiveness and outcomes research related to medications, medical devices, procedures, and healthcare delivery interventions. Faculty and staff in the division have advanced training in health services research, pharmacoepidemiology, and decision science methods, and work collaboratively with clinical researchers who have expertise in a variety of medical and surgical specialties.
Examples of areas of faculty research include comparative effectiveness and cost-effectiveness of preventing, diagnosing, and treating chronic and acute infectious diseases; cardiovascular medical device safety monitoring and evidence synthesis; evaluation of total joint replacement outcomes using registry and administrative data; pharmacoepidemiology and comparative effectiveness of diabetes drugs; and comparative effectiveness and cost-effectiveness of alternatives to methadone to treat opioid use disorder.
Division of Comparative Effectiveness and Outcomes Research
Department of Healthcare Policy and Research
Weill Cornell Medical College
425 East 61st Street
New York, NY 10065
- Division Office
- (646) 962-9307
Selected Recent Publications
- Flory JH, Roy J, Gagne JJ, Haynes K, Herrinton L, Lu C, Patorno E, Shoaibi A, Raebel MA. Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk. J Comp Eff Res. 2017 Jan;6(1):25-32.
- Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HA, Schackman BR. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. Health Aff (Millwood). 2016 Jun 1;35(6):1045-51
- Feaster DJ, Parish CL, Gooden L, Matheson T, Castellon PC, Duan R, Pan Y, Haynes LF, Schackman BR, Malotte CK, Mandler RN, Colfax GN, Metsch LR. Substance use and STI acquisition: Secondary analysis from the AWARE study. Drug Alcohol Depend. 2016 Dec 1;169:171-179.
- Vgenas P, Zelenev A, Altice FL,2, Di Paola A, Jordan AO, Teixeira PA, Frew PM, Spaulding AC, Springer SA. HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. AIDS Care. 2016;28(1):22-31.
- Lucas KD, Eckert V, Behrends CN, Wheeler C, MacGowan RJ, Mohle-Boetani JC. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012. MMWR Morb Mortal Wkly Rep. 2016 Feb 26;65(7):178-81.
- Wittenberg E, Bray JW, Aden B, Gebremariam A, Nosyk B, Schackman BR. Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population. Addiction. 2016 Apr;111(4):675-84
- Bloch EM, Simon MS, Shaz BH. Emerging Infections and Blood Safety in the 21st Century. Ann Intern Med. 2016 Mar 15
- Simon MS, Weiss D, Geevarughese A, Kratz MM, Cutler B, Gulick RM, Zucker JR, Varma JK, Schackman BR. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City. J Acquir Immune Defic Syndr. 2016;71(2):146-154. PMID: 26334735
- Schackman BR, Eggman AA, Leff JA, Braunlin M, Felsen UR, Fitzpatrick L, Telzak EE, El-Sadr W, Branson BM. Costs of Expanded Rapid HIV Testing in Four Emergency Departments. Public Health Rep. 2016;131 Suppl 1:71-81. PMID: 26862232
- Pandya A, Eggman AA, Kamel H, Gupta A, Schackman BR, Sanelli PC. Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke. PLoS One. 2016;11(2):e0148106. PMID: 26840397
- Aden B, Dunning A, Nosyk B, Wittenberg E, Bray JW, Schackman BR. Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment. J Acquir Immune Defic Syndr. 2015;70(3):304-310. PMID: 26218410
- Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015;162(9):619-629. PMID: 25820703
- Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BP. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction. 2015;110(1):129-143. PMID: 25291977
- J Bone Joint Surg Am • 2015 • Hassan Ghomrawi, Ashley Eggman, Andrew Pearle
Effect of age on cost-effectiveness of unicompartmental knee arthroplasty compared with total knee arthroplasty in the U.S.
- Med Care • 2015 • Bruce Schackman et al
The Lifetime Medical Cost Savings from Preventing HIV in the United States
- JAMA Surg • 2015 • Jialin Mao, Xi Emily Zheng, Art Sedrakyan, et al
Population-Based Estimates of the Prevalence of Uterine Sarcoma Among Patients With Leiomyomata Undergoing Surgical Treatment